Negishi, Japan

Mamoru Shinano

This inventor holds 1 USPTO granted patent. Top assignee: Toho Chemical Industry Co., Ltd.. Active years: 1982.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mamoru Shinano. Retrieved from https://idiyas.com/inventor/mamoru-shinano

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 1982

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Mamoru Shinano: Innovator in Antibacterial Technology

Introduction

Mamoru Shinano is a notable inventor based in Negishi, Japan. He has made significant contributions to the field of antibacterial technology. His work focuses on developing innovative solutions that address pressing health concerns.

Latest Patents

Mamoru Shinano holds a patent for an antibacterial surface active agent containing azaalkenelactam. This invention showcases his commitment to advancing antibacterial solutions that can be utilized in various applications.

Career Highlights

Shinano is associated with Toho Chemical Industry Co., Ltd., where he has been instrumental in research and development. His expertise in chemistry and innovation has led to the creation of effective antibacterial agents.

Collaborations

One of his notable collaborators is Hiroyoshi Hamanaka. Together, they have worked on projects that enhance the effectiveness of antibacterial products.

Conclusion

Mamoru Shinano's contributions to antibacterial technology highlight his role as an innovator in the field. His patent and collaboration with industry professionals underscore the importance of ongoing research in health-related innovations.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…